ES / EN
- June 29, 2022 -
No Result
View All Result
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
ADVERTISEMENT
Home Cuba

Cuban COVID-19 nasal vaccine concludes first phase of trials

The drug, developed by scientists from the Cuban Center for Genetic Engineering and Biotechnology (CIGB), began human trials on December 7 with 88 volunteers, explained the head of the trial, Miladys Limonta.

by OnCuba Staff, OnCuba editorial staff
January 19, 2021
in Cuba
0
Photo: CIGBCuba/Twitter.

Photo: CIGBCuba/Twitter.

The Cuban Mambisa COVID-19 vaccine candidate concluded the period of clinical trials called “short cycle,” stipulated for days zero, 14 and 28 of the schedule, Prensa Latina reported.

The drug, developed by scientists from the Cuban Center for Genetic Engineering and Biotechnology (CIGB), began human trials on December 7 with 88 volunteers, explained the head of the trial, Miladys Limonta.

#Mambisa y #Abdala, actualmente en Fase I de ensayos clínicos, los científicos cubanos se preparan para actuar ante variantes de la enfermedad con mayor capacidad de infección y de agravar los daños a la salud.https://t.co/6zDC4XnpHw pic.twitter.com/mPdJMSrAAA

— CIGBCuba (@CIGBCuba) January 16, 2021

The study participants received an intramuscular dose of the drug and another two intranasal doses, while another group received three administrations by the same route, indicates the source, citing the expert.

After the first period of the trials, the safety of the vaccine candidate could be verified, as there were only mild adverse reactions, Limonta said.

Once the evaluation of the results of the study by the Cuban regulatory entity has concluded, “we would move on to the long cycle, between days zero, 28 and 56,” the scientist explained.

The other COVID-19 vaccine candidate developed by the CIGB also completed its short cycle that evaluates the dose ranges in a period of zero, 14 and 28 days, study leaders announced.

The clinical trials of the drug Abdala include 132 volunteers, who receive two doses of antigen or placebo intramuscularly.

Cuba inicia segunda fase de ensayos clínicos de su candidato vacunal Soberana 02

In the midst of the worst outbreak of coronavirus infections, Cuba is pinning its hopes on four drugs to immunize the population.

In addition to Mambisa and Abdala, the island has the vaccine candidates developed by the Finlay Institute: Soberana 01 and Soberana 02, the latter in phase II of clinical trials.

On December 17, after preliminary positive results of phase I, Sovereign 02 received authorization from the Center for State Control of Medicines, Equipment and Medical Devices to advance to the next phase of clinical trials, therefore being the first Latin American drug to reach that stage.

Authors

OnCuba Staff, OnCuba editorial staff
Tags: coronavirus in CubaCOVID-19 vaccineCuban science
Previous Post

We were also record holders in terms of devils

Next Post

With today’s 417 discharges, more than 14,000 people have recovered from COVID-19 in Cuba

OnCuba Staff

OnCuba Staff

Next Post

With today’s 417 discharges, more than 14,000 people have recovered from COVID-19 in Cuba

Animal welfare in Cuba: the regulations to come (I)

SARS-CoV-2 death toll stands at 180 in Cuba after five new fatalities

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

Most Read

  • Cuba: bad decisions and energy crisis

    14 shares
    Share 6 Tweet 4
  • UN agency makes million dollars’ worth of investment in Cuban agriculture

    11 shares
    Share 4 Tweet 3
  • Russia in the face of the “new war normality”

    8 shares
    Share 3 Tweet 2
  • Cuban stars in Miami

    70 shares
    Share 28 Tweet 18
  • Renewable energies’ ambitious route in Cuba

    6 shares
    Share 2 Tweet 2

Most Commented

  • The Enchanted Shrimp of the Cuban Dance

    831 shares
    Share 332 Tweet 208
  • Patricia: a pain before the mirror

    3 shares
    Share 1 Tweet 1
  • Families divided between Cuba and Canada due to immigration procedures

    77 shares
    Share 72 Tweet 2
  • Online stores in Cuba: a single purchase per day

    82 shares
    Share 59 Tweet 10
  • New version of Family Code draft presented in Cuba

    14 shares
    Share 6 Tweet 4
  • About us
  • Work with OnCuba
  • Terms of use
  • Privacy Policy
  • Moderation policy for comments
  • Contact us
  • Advertisement offers

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

No Result
View All Result
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

Exit mobile version